1st Quarter - Report

HEALTH AND MEDICINE COUNSEL for DIGESTIVE DISEASE NATIONAL COALITION

Firm
Client
Income
$10,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Functional Gastrointestinal & Motility Disorder (FGIMD) Research Enhancement Act Medicare Home Infusion Therapy Coverage The CT Colonography Screening for Colorectal Cancer Act The Patients Access to Treatments Act The Medical Nutrition Equity Act NIH research funding for digestive diseases CDC funding for digestive disease surveillance & screening programs FDA-Biosimilar Regulatory Pathway The Safe Step Act COVID-19 Relief Packages

LobbyistCovered position, as disclosed
DALE P DIRKS Legislative Consultant
JACKSON RAU Legislative Consultant

Contacted: Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA); Veterans Affairs, Dept of (VA); Natl Institutes of Health (NIH); SENATE; HOUSE OF REPRESENTATIVES; Defense, Dept of (DOD)

Budget/Appropriations BUD

House/Senate L-HHS Appropriations Bills House/Senate Mil-Con VA Appropriations Bill House/Senate Defense Appropriations Bill FDA funding Food Safety Bill Implementation Digestive Health legislation NIH funding CDC funding Dept of Defense Peer Reviewed Medical Research Program COVID-19 Supplemental Appropriations Dept of VA Medical & Prosthetic Research Program Dept of Defense Cancer Research Program ACA Implementation Cost-Shifting Issues Step Therapy Legislation

LobbyistCovered position, as disclosed
DALE P DIRKS Legislative Consultant
JACKSON RAU Legislative Consultant

Contacted: Veterans Affairs, Dept of (VA); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); Food & Drug Administration (FDA); SENATE; Centers For Disease Control & Prevention (CDC); Defense, Dept of (DOD)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.